Suppression of osteosarcoma progression by engineered lymphocyte-derived proteomes

Cancer cells tend to develop resistance to chemotherapy and enhance aggressiveness. A counterintuitive approach is to tame aggressiveness by an agent that acts opposite to chemotherapeutic agents. Based on this strategy, induced tumor-suppressing cells (iTSCs) have been generated from tumor cells an...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Genes and Diseases
Main Authors: Kexin Li, Xun Sun, Hudie Li, Hailan Ma, Meng Zhou, Kazumasa Minami, Keisuke Tamari, Kazuhiko Ogawa, Pankita H. Pandya, M. Reza Saadatzadeh, Melissa A. Kacena, Karen E. Pollok, Bai-Yan Li, Hiroki Yokota
Format: Artigo
Izdano: KeAi Communications Co., Ltd. 2023-07-01
Teme:
Calreticulin
Lymphocytes
Moesin
Osteosarcoma
PKA
Proteome
Online dostop:http://www.sciencedirect.com/science/article/pii/S2352304222002288
Oznake: Označite
Brez oznak, prvi označite!

Internet

http://www.sciencedirect.com/science/article/pii/S2352304222002288

Podobne knjige/članki